HIV/AIDS Research
RNA interference against PARP-1 efficiently suppresses HIV-1 replication
Published in AIDS Weekly, October 18th, 2004
"We established small interfering RNA (siRNA) directed against poly(ADP-ribose) polymerase 1 (PARP-1) that effectively reduces the expression of PARP-1 in two human cell lines," scientists writing in the Journal of Virology report.
"Established siRNA against PARP-1 significantly suppressed human immunodeficiency virus type 1 (HIV-1) replication," said M. Kameoka and coworkers, "as well as the activation of the integrated HIV-1 long terminal repeat promoter."
"These results indicate that PARP-1 is required for efficient HIV-1 replication in human...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-10-18)
More Articles from AIDS Weekly
- GB Virus C
GB virus C viremia associated with increased quality of life in HIV infection - HIV/AIDS Research
Single-LTR HIV-1 vector is optimized for functional genomics applications - HIV/AIDS Therapy
Phenotypic susceptibility predictive of HIV-1 RNA response in PI users - HIV/AIDS Treatment
Few patients have good virological response after 2 years treatment interruption - HIV/AIDS-Associated Insulin Resistance
Novel insulin receptor activator prevents PI-induced insulin resistance - AIDS/HIV Diagnosis
Rapid and conventional testing methods for HIV screening compared - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
